Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05197881 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05197881 · ClinicalTrials.gov record · last posted 2025-09-23

Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

Study acronym: ARTIA-Cervix
StatusRecruiting
PhaseNot applicable
Started2022-05-03
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a single-arm, prospective, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for locally advanced cervical cancer will translate into a decreased rate of acute gastrointestinal toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT). The timepoint for this assessment will be at week 5 of external beam radiotherapy (EBRT) and will use the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Amendment record 7 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 7 times since 2022-01-13; most recent amendment 2025-09-19. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-06-07
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT05197881
Lead Sponsor Varian, a Siemens Healthineers Company
Conditions Cervical Cancer by FIGO Stage 2018
Enrollment 125 participants
Start Date 2022-05-03
Primary Completion 2028-09 (estimated)
Study Completion 2030-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-23